PMID- 16715365 OWN - NLM STAT- MEDLINE DCOM- 20070213 LR - 20181113 IS - 0724-8741 (Print) IS - 0724-8741 (Linking) VI - 23 IP - 6 DP - 2006 Jun TI - FTIR and nDSC as analytical tools for high-concentration protein formulations. PG - 1350-63 AB - PURPOSE: The aim of the study is to evaluate Fourier-transform infrared spectroscopy (FTIR) as an analytical tool for high-concentrated protein formulations. METHODS: FTIR is used to determine the melting temperature (T(m (FTIR))) of various proteins, such as bovine serum albumin (BSA), immunoglobulin (IgG1), beta-lactoglobulin (beta-LG), and lysozyme (HEWL), at different protein concentrations (5-100 mg/mL), where four data interpretation methods are discussed. The obtained T(m (FTIR)) values are further compared to the T(m) measured by the nanodifferential scanning calorimetry (nDSC) technique. RESULTS: The T(m (FTIR)) values of IgG1 and beta-LG showed strong consistency and corresponded to the nDSC results irrespective of the method of data interpretation and the protein concentration applied. In contrast, the T(m (FTIR)) of BSA and HEWL is characterized by significant deviations. Only the midpoint of the second-derivative intensity-temperature curve of the intermolecular beta-sheet mode measured at a concentration of 100 mg/mL is consistent with the nDSC results. CONCLUSIONS: Determination of a T(m (FTIR)) is feasible by the midpoint of the intensity-temperature plot of the arising intermolecular beta-sheet band. More significant results are obtained for proteins, which are predominantly composed of intramolecular beta-sheet elements as well as at higher protein concentrations. A further study was started to assess the predictability of long-term protein stability by T(m (FTIR)). FAU - Matheus, Susanne AU - Matheus S AD - Merck KGaA, Global Pharmaceutical Development, Darmstadt, Germany. FAU - Friess, Wolfgang AU - Friess W FAU - Mahler, Hanns-Christian AU - Mahler HC LA - eng PT - Comparative Study PT - Journal Article DEP - 20060526 PL - United States TA - Pharm Res JT - Pharmaceutical research JID - 8406521 RN - 0 (Immunoglobulin G) RN - 0 (Lactoglobulins) RN - 27432CM55Q (Serum Albumin, Bovine) RN - EC 3.2.1.17 (Muramidase) SB - IM MH - *Calorimetry, Differential Scanning MH - Chemistry, Pharmaceutical MH - Enzyme Stability MH - Immunoglobulin G/*chemistry MH - Lactoglobulins/*chemistry MH - Muramidase/*chemistry MH - *Nanotechnology MH - Protein Denaturation MH - Protein Folding MH - Protein Structure, Secondary MH - Serum Albumin, Bovine/*chemistry MH - *Spectroscopy, Fourier Transform Infrared MH - Thermodynamics MH - Transition Temperature EDAT- 2006/05/23 09:00 MHDA- 2007/02/14 09:00 CRDT- 2006/05/23 09:00 PHST- 2005/11/10 00:00 [received] PHST- 2006/01/27 00:00 [accepted] PHST- 2006/05/23 09:00 [pubmed] PHST- 2007/02/14 09:00 [medline] PHST- 2006/05/23 09:00 [entrez] AID - 10.1007/s11095-006-0142-8 [doi] PST - ppublish SO - Pharm Res. 2006 Jun;23(6):1350-63. doi: 10.1007/s11095-006-0142-8. Epub 2006 May 26.